Researchers have identified two genes that is responsible for identifying the risk of bleeding in patients receiving anticoagulant warfarin appear. To New England Journal of Medicine About 2 million Americans take warfarin after a heart attack, stroke or surgery. According to the specialists accurately calculate the dose to prevent thrombosis without causing bleeding. Scientists examined DNA 297 patients who have just started taking warfarin and found two genes (CYP2C9 and VKORC1) that took place in the reactions to the drug, and help you on the further reaction to the medication to learn. According to scientists can predict the analysis of the changes in the gene VKORC1, the reaction of the human body only, the initial dose of warfarin.
No comments:
Post a Comment